In addition, accumulating evidence supports a role for HMGA2 in epithelial-mesenchymal transition (EMT) in various cancers including pancreatic, prostate and colorectal cancer [13,14,15], and its function as a modulator of the TGFβ signaling pathway [16]. Here, HMGA2 is linked to cancer.